Biological Effects of High Level c-myc Expression in FR3T3 Fibroblasts

  • M. Zerlin
  • M. A. Julius
  • C. Cerni
  • K. B. Marcu
Conference paper
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 132)


The contribution(s) made by the c-myc proto-oncogene to cellular transforation remains obscure and controversial. Introduction of a c-myc gene into primary fibroblast cells facilitates continuous growth in vitro yet these cells retain a normal morphology, are unable to grow in soft agar and, are not tumorigenic in syngeneic hosts or athymic mice (Land et al. 1983; Mougneau et al. 1984; Connan et al. 1985). C-myc activity has also been associated with the competency of cells to enter and progress through the cell cycle (Thompson et al. 1985; Kaczmarek et al. 1985). This picture of c-myc gene function loses its apparent simplicity within the context of cell lines that have been established spontaneously in culture. An activated c-myc gene within certain immortalized cell lines such as Rat2 (Topp 1981) or NIH3T3 (Jainchill et al. 1969) for example, promotes growth in low serum and in soft agar at low efficiency and, converts cells to a tumorigenic phenotype (Keath et al. 1984; Kelekar and Cole 1986). By these latter criteria c-myc could be considered a transforming gene.


Soft Agar Early Passage Late Passage Polyoma Virus Fibroblast Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Cairns J (1975) fetation selection and the natural history of cancer. Nature 255:197–200.Google Scholar
  2. Connan G, Rassoulzadegan M, Cuzin F (1985) Focus formation in rat fibroblasts exposed to a tumour promoter after transfer of polyoma pit and myc oncogenes. Nature 314: 277–279.PubMedCrossRefGoogle Scholar
  3. Fort Ph, Marty L, Piechaczyk M, Sabrouty S El, Dani Ch, Janteur Ph, Blanchard JM (1985) Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigenic family. Nucleic Acids Res. 13: 1431–1442.PubMedCrossRefGoogle Scholar
  4. Jainchill JS, Aaronson SA, Tbdaro GJ (1969) Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J. Virol. 4: 549–553.PubMedGoogle Scholar
  5. Kaczmarek L, Hyland JKf Watt R, Rosenberg M and Baserga R (1985) Microinjected c-myc as a competence factor. Science 228: 1313–1315.Google Scholar
  6. Keath EJ, Caimi PG, Cole MD (1984) Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals. Cell 39: 339–348.PubMedCrossRefGoogle Scholar
  7. Kelekar A, Cole MD (1986) Tumorigenicity of fibroblast lines expressing the adenovirus Elaf cellular p53f or normal c-myc genes. Mol Cell Biol 6: 7–14.PubMedGoogle Scholar
  8. Klein G, Klein E (1985) Evolution of tumours and the impact of molecular oncology. Nature 315: 190–195.PubMedCrossRefGoogle Scholar
  9. Kriegler M, Perez CF, Hardy C and Botchan M (1984) Transformation mediated by SV40 T antigens: separation of overlapping SV40 early genes with a retroviral vector. Cell 38: 483–491.PubMedCrossRefGoogle Scholar
  10. Land Hf Parada LF, Weinberg RA (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596–602.Google Scholar
  11. Lee WF, Schwab M, Westway D, Varmus HE (1985) Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene. Mol Cell Biol 5: 3345–3356.PubMedGoogle Scholar
  12. Mougneau E, Lemieux L, Rassoulzadegan M, Cuzin F (1984) Biological activities of the v-myc and of rearranged c-myc oncogenes in rat fibroblast cells in culture. Proc Natl Acad Sci USA 81: 5758–5762.PubMedCrossRefGoogle Scholar
  13. Rassoulzadegan Mf Cowie A, Carr A, Glaichenhaus N, Kamen Rf Cuzin F. (1982) The roles of individual polyoma virus early proteins in oncogenic transformation. Nature 300: 713–718.Google Scholar
  14. Seif Rf Cuzin F (1977) Temperature-sensitive growth regulation in one type of transformed rat cells induced by the tsa mutant of polyoma virus. J. Virology 24: 721–728.Google Scholar
  15. Southern PJ, Berg P (1982) Transformation of mammalian cells to antibiotic resistance with a bacterial gene under the control of the SV40 early region promoter. J Mol Appl Genet 1: 327–341.PubMedGoogle Scholar
  16. Stanton IM, Watt R, Marcu KB (1983) Translocation, breakage, and truncated trans¬cripts of c-myc oncogene in murine plasmacytomas. Nature 303: 401–406.PubMedCrossRefGoogle Scholar
  17. Stern DF, Roberts AB, Roche NS, Sporn MB, Weinberg RA (1986) Differential responsiveness of myc and ras-transfected cells to growth factors: selective stimulation of c-myc transfected cells by epidermal growth factor. Mol Cell Biol 6: 870–877.PubMedGoogle Scholar
  18. Thomas PS (1980) Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 77: 5201–5205.PubMedCrossRefGoogle Scholar
  19. Thompson CB, Challoner PB, Neiman PE and Groudine M (1985) Levels of c-myc oncogene are invariant throughout the cell cycle. Nature 314: 363–366.PubMedCrossRefGoogle Scholar
  20. Topp WC (1981) Normal rat cell lines deficient in nuclear thymidine kinase. Virology 113: 408 - 411.PubMedCrossRefGoogle Scholar
  21. Zeevi M, Nevins JR, Darnell JE Jr (1981) Nuclear RNA is spliced in the absence of poly (A)+addition. Cell 26: 39–46.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1986

Authors and Affiliations

  • M. Zerlin
    • 1
  • M. A. Julius
    • 1
  • C. Cerni
    • 2
  • K. B. Marcu
    • 1
  1. 1.Biochemistry DepartmentSUNY at Stony BrookStony BrookUSA
  2. 2.Tumor Biology InstituteViennaAustria

Personalised recommendations